Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain Stem Tumors.

Ira J Dunkel1, Mark M Souweidane

  • 1Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, Box 185, 1275 York Avenue, New York, NY 10021, USA. dunkeli@mskcc.org.

Current Treatment Options in Neurology
|June 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Ancestral genetic homogeneity in preclinical models may shape outcome differences in pediatric brain cancer.

Cancer research·2026
Same author

Developing a core outcome set for the NeuroPoint Alliance Quality Outcomes Database Pediatric Tumor Surgery Registry: a modified Delphi study.

Journal of neuro-oncology·2026
Same author

Safety of focused ultrasound in neuro-oncology: A summary of preclinical and clinical work.

Neuro-oncology advances·2026
Same author

Impact of cranial irradiation on the clinical presentation of cerebral cavernous malformations.

Clinical neurology and neurosurgery·2026
Same author

Diffuse midline glioma with extra central nervous system metastases in the pediatric, adolescent, and young adult population.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Diffuse pontine tumors are aggressive pediatric brain cancers with poor prognoses. Research into new therapies, including interstitial infusion and autopsy studies, is crucial for developing effective treatments.

Area of Science:

  • Neuro-oncology
  • Pediatric oncology
  • Tumor biology

Background:

  • Brain stem tumors exhibit significant heterogeneity, impacting prognosis and treatment.
  • Diffuse pontine tumors, though rare, are a major cause of mortality in pediatric cancer patients.
  • Current therapies offer limited efficacy for diffuse pontine tumors.

Purpose of the Study:

  • To review the epidemiology of brain stem tumors.
  • To highlight the challenges in diagnosing and treating diffuse pontine tumors.
  • To explore novel therapeutic strategies and research avenues.

Main Methods:

  • Review of epidemiological data on brain stem tumors.
  • Discussion of diagnostic approaches, primarily magnetic resonance imaging.

Related Experiment Videos

  • Analysis of current treatment limitations and future research directions.

    • Main Results:

    • Diffuse pontine tumors are characterized by a poor prognosis despite available therapies.
    • Magnetic resonance imaging is the standard diagnostic tool, often obviating the need for biopsy.
    • Conventional radiation therapy offers short-term palliation, but no highly effective standard treatment exists.

    Conclusions:

    • Clinical research participation is vital for patients with diffuse pontine tumors.
    • Interstitial infusion of therapeutic agents represents a promising preclinical research area.
    • Autopsy studies are essential for acquiring tumor tissue to advance novel therapy development.